Literature DB >> 18708619

Deletion of the FHL2 gene attenuating neovascularization after corneal injury.

Pao-Hsien Chu1, Lung-Kun Yeh, Hsin-Chiung Lin, Shih-Ming Jung, David Hui-Kang Ma, I-Jong Wang, Hsueh-Hua Wu, Tzu-Fang Shiu, Ju Chen.   

Abstract

PURPOSE: The four-and-one-half LIM domain-containing protein2 (FHL2) is a member of the four-and-a-half LIM domain-only (FHL) gene family. Although FHL2 is expressed in the cornea, its role in angiogenesis is unclear. The aim of this study was to investigate the role of the FHL2 gene in corneal angiogenesis after chemical injury.
METHODS: FHL2-LacZ knock-in mice were used to trace FHL2 gene expression before and after corneal injury. Corneal angiogenesis between FHL2-null mice and wild-type mice that underwent chemical and mechanical denudation of corneal and limbal epithelium were compared. New growth vessel density was assessed by CD31 staining and was analyzed using image analysis software. Levels of vascular endothelial growth factor (VEGF) and cyclooxygenase (COX)-2 proteins were determined by Western blot assay.
RESULTS: beta-Galactosidase staining of corneal tissue in FHL2-LacZ knock-in mice revealed that FHL2 gene expression is upregulated in the corneal epithelium after corneal injury. Ten days after injury, corneal neovascularization was observed in control and FHL2-null mice. New corneal vessel density was found to be lower in the FHL2-null mice injury group than in the wild-type mice injury group. Western blot analysis showed that VEGF and COX-2 protein levels were higher after chemical injury in FHL2-null mice and wild-type mice. However, the upregulated VEGF protein was significantly lower in the FHL2-null mice than in the wild-type mice.
CONCLUSIONS: The decreased chemical-induced corneal angiogenesis found in the FHL2-null mice in this study indicated that FHL2 protein plays a role in inhibiting inflammatory angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708619      PMCID: PMC2738584          DOI: 10.1167/iovs.08-2209

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  34 in total

1.  Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.

Authors:  W Philipp; L Speicher; C Humpel
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

Review 2.  Role of vascular endothelial growth factor in diabetic vascular complications.

Authors:  L P Aiello; J S Wong
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

3.  Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.

Authors:  A J Marrogi; W D Travis; J A Welsh; M A Khan; H Rahim; H Tazelaar; P Pairolero; V Trastek; J Jett; N E Caporaso; L A Liotta; C C Harris
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

4.  Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system.

Authors:  P H Chu; P Ruiz-Lozano; Q Zhou; C Cai; J Chen
Journal:  Mech Dev       Date:  2000-07       Impact factor: 1.882

5.  Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.

Authors:  A K Ghosh; N Hirasawa; H Niki; K Ohuchi
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

6.  Host cyclooxygenase-2 modulates carcinoma growth.

Authors:  C S Williams; M Tsujii; J Reese; S K Dey; R N DuBois
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Authors:  J L Masferrer; K M Leahy; A T Koki; B S Zweifel; S L Settle; B M Woerner; D A Edwards; A G Flickinger; R J Moore; K Seibert
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

8.  FHL2 (SLIM3) is not essential for cardiac development and function.

Authors:  P H Chu; W M Bardwell; Y Gu; J Ross; J Chen
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Differential expression of VEGF isoforms in mouse during development and in the adult.

Authors:  Y S Ng; R Rohan; M E Sunday; D E Demello; P A D'Amore
Journal:  Dev Dyn       Date:  2001-02       Impact factor: 3.780

View more
  6 in total

1.  Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.

Authors:  Szu-Yuan Li; Po-Hsun Huang; Der-Cherng Tarng; Tzu-Ping Lin; Wu-Chang Yang; Yen-Hwa Chang; An-Hang Yang; Chih-Ching Lin; Muh-Hwa Yang; Jaw-Wen Chen; Geert W Schmid-Schönbein; Shu Chien; Pao-Hsien Chu; Shing-Jong Lin
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

2.  Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.

Authors:  Charlotte Labalette; Yann Nouët; Florence Levillayer; Sabine Colnot; Ju Chen; Valere Claude; Michel Huerre; Christine Perret; Marie-Annick Buendia; Yu Wei
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

Review 3.  Corneal transparency: genesis, maintenance and dysfunction.

Authors:  Yureeda Qazi; Gilbert Wong; Bryan Monson; Jack Stringham; Balamurali K Ambati
Journal:  Brain Res Bull       Date:  2009-05-27       Impact factor: 4.077

4.  Critical role of Klf5 in regulating gene expression during post-eyelid opening maturation of mouse corneas.

Authors:  Doreswamy Kenchegowda; Stephen A K Harvey; Sudha Swamynathan; Kira L Lathrop; Shivalingappa K Swamynathan
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

Review 5.  How (Epi)Genetic Regulation of the LIM-Domain Protein FHL2 Impacts Multifactorial Disease.

Authors:  Jayron J Habibe; Maria P Clemente-Olivo; Carlie J de Vries
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

6.  Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis.

Authors:  Chen Wang; Xiangmin Lv; Chunbo He; John S Davis; Cheng Wang; Guohua Hua
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.